Phase I trial in Rwanda and South Africa aims to evaluate mRNA HIV vaccine antigen for safety and immunogenicity and strengthen regional scientific capacity
Leading this effort was Cytel’s principal research scientist and Professor of Health Research Methods at McMaster University in Canada, Dr. Edward Mills
Deucravacitinib is currently under regulatory review in multiple regions, including the U.S., Europe and Japan, and would be the first selective allosteric tyrosine kinase 2 (TYK2) inhibitor approved for the treatment of any disease
The partners also aim to expand their work to Latin America for the first time
To lay a technological foundation for developing exosome-based medicines and cosmetic products for dermatitis treatment
The new building is expected to be commissioned by 2024. Post the expansion, Nanavati-Max Hospital will be amongst the largest private sector hospital in western India
The company enters into collaborations with leading next-generation sequencing (NGS) companies to facilitate trial enrollment for PRECISION 1, the Company’s Phase 2 registrational trial
Survey findings released in advance of World Lupus Day on May 10
This agreement is truly remarkable for achieving greater objectives in the projects and addressing larger problems
The report has estimated 4.74 million deaths for India in 2020 and 2021,
Subscribe To Our Newsletter & Stay Updated
